65,437 trials
Hypertension
Primary: Mean Change From Baseline to Week 4 in Systolic Blood Pressure (SBP) — -6.0; -8.9; -12.0 mm Hg
Hypertension
Primary: Change From Baseline to Week 12 in Systolic BP (SBP) as Measured by 24-hour ABPM. — -20.4 mm Hg — p=<0.0001
Hepatitis B
Primary: Number of Subjects With an Immune Response to a Challenge Dose of Hepatitis B Vaccine — 28 subjects
Osteoporosis
Primary: Proportion of Patients With a Clinically Significant Increase in Oral Body Temperature or Use of Rescue Medication. — 0.607; 0.398; 0.618; 0.39 proportion of patients
Hypertension
Primary: Change in Mean Sitting Diastolic Blood Pressure (msDBP) From Baseline to End of Study (Week 8) — -10.8; -6.3; -7.2 mmHg
Overactive Bladder
Primary: Change in Mean Number of Micturition Episodes Per 24 Hours at Week 12 Relative to Baseline. — -2.1; -2.9 number of episodes per 24 hours — p=0.0002
Migraine
Primary: Change From Baseline in Mean Migraine Headache Rates During the Entire 14-week Maintenance Period — -1.4; -1.4; -1.6 Number of migraine headaches
Diabetes Mellitus Type 2
Primary: Percent Change at Week (Wk) 12 Compared to Baseline (Bl) in Low-density Lipoprotein Cholesterol in Patients With Type 2 Diabetes When Compared to Placebo — -15.8; 2.1…
Hypertension
Primary: Change From Baseline in Mean 24-hour Ambulatory Systolic Blood Pressure After 12 Weeks of Active Treatment — -25.7 mm Hg — p=<0.0001
Disaster Medicine · Difficult Intravenous Access · Dehydration
Primary: Number of Participants With Successfully Placed EASI Lines — 18 Participants
Influenza
Primary: Number of Participants With Laboratory-Confirmed Clinical Influenza, ITT Population — 7; 5 participants — p=0.772
Hepatitis C, Chronic
Primary: Sustained Virologic Response — 87; 117 participants — p=< 0.001
Heart Valve Diseases
Primary: Intensity (Highness) of the Sound From Mechanical Heart Valves — 43; 41; 40 dB (decibel) — p=<0.05
Tibial Fractures
Primary: Number of Patients With Healed Fractures — 83; 66; 8; 13 patients — p=0.0541
Acute Myeloid Leukemia
Primary: Complete Response = Morphologic Complete Remission (mCR) — 13 Participants